Abiomed Inc (ABMD)

263.84 +8.62  +3.38% NASDAQ Jul 2, 20:00 Delayed 2m USD

Abiomed Cash from Financing (TTM):

-117.72M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 1986. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 -117.72M
Dec. 31, 2019 -92.93M
Sept. 30, 2019 -69.10M
June 30, 2019 -33.25M
March 31, 2019 -55.78M
Dec. 31, 2018 -56.24M
Sept. 30, 2018 -53.52M
June 30, 2018 -56.50M
March 31, 2018 -9.137M
Dec. 31, 2017 -1.288M
Sept. 30, 2017 0.10M
June 30, 2017 0.655M
March 31, 2017 3.867M
Dec. 31, 2016 -4.641M
Sept. 30, 2016 -7.362M
June 30, 2016 -5.272M
March 31, 2016 7.16M
Dec. 31, 2015 6.783M
Sept. 30, 2015 12.57M
June 30, 2015 10.93M
March 31, 2015 9.523M
Dec. 31, 2014 9.527M
Sept. 30, 2014 6.372M
June 30, 2014 7.934M
March 31, 2014 9.632M
   
Dec. 31, 2013 4.185M
Sept. 30, 2013 -9.132M
June 30, 2013 -11.30M
March 31, 2013 -11.81M
Dec. 31, 2012 -5.186M
Sept. 30, 2012 9.208M
June 30, 2012 8.041M
March 31, 2012 14.68M
Dec. 31, 2011 12.79M
Sept. 30, 2011 8.875M
June 30, 2011 8.909M
March 31, 2011 1.374M
Dec. 31, 2010 0.823M
Sept. 30, 2010 0.922M
June 30, 2010 0.981M
March 31, 2010 0.979M
Dec. 31, 2009 0.911M
Sept. 30, 2009 1.79M
June 30, 2009 43.89M
March 31, 2009 46.23M
Dec. 31, 2008 47.24M
Sept. 30, 2008 45.02M
June 30, 2008 3.14M
March 31, 2008 2.07M
Dec. 31, 2007 65.50M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Benchmarks
Baxter International Inc 1.43B
Gilead Sciences Inc -7.879B
IDEXX Laboratories Inc -266.73M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -117.72M Mar 2020
Maximum 12.57M Sep 2015
Average -27.98M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.